Does BROMAZEPAM Cause Hepatic cytolysis? 31 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 31 reports of Hepatic cytolysis have been filed in association with BROMAZEPAM. This represents 0.5% of all adverse event reports for BROMAZEPAM.
31
Reports of Hepatic cytolysis with BROMAZEPAM
0.5%
of all BROMAZEPAM reports
9
Deaths
14
Hospitalizations
How Dangerous Is Hepatic cytolysis From BROMAZEPAM?
Of the 31 reports, 9 (29.0%) resulted in death, 14 (45.2%) required hospitalization, and 10 (32.3%) were considered life-threatening.
Is Hepatic cytolysis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BROMAZEPAM. However, 31 reports have been filed with the FAERS database.
What Other Side Effects Does BROMAZEPAM Cause?
Drug abuse (964)
Toxicity to various agents (914)
Coma (790)
Somnolence (641)
Intentional overdose (467)
Poisoning deliberate (419)
Fall (385)
Hypotension (375)
Drug use disorder (351)
Suicide attempt (345)
What Other Drugs Cause Hepatic cytolysis?
ACETAMINOPHEN (1,469)
ATORVASTATIN (681)
PEMBROLIZUMAB (601)
CARBOPLATIN (577)
METHOTREXATE (468)
SULFAMETHOXAZOLE\TRIMETHOPRIM (356)
PACLITAXEL (324)
ENOXAPARIN (307)
AMOXICILLIN (273)
VALACYCLOVIR (261)
Which BROMAZEPAM Alternatives Have Lower Hepatic cytolysis Risk?
BROMAZEPAM vs BROMFENAC
BROMAZEPAM vs BROMHEXINE
BROMAZEPAM vs BROMOCRIPTINE
BROMAZEPAM vs BROTIZOLAM
BROMAZEPAM vs BUCILLAMINE